Acute undifferentiated leukemia
MONDO:0020321A rare acute leukemia of ambiguous lineage in which the blasts do not express markers specific to myeloid or lymphoid lineage.
Also known as: acute myeloid leukemia, minimal differentiation, FAB M0, acute undifferentiated leukemia, leukaemia stem cell, leukemia stem cell, stem cell acute leukaemia, stem cell acute leukemia, stem cell leukaemia, stem cell leukemia
3117 clinical trials for this condition and its sub-types, 27 tagged with Acute undifferentiated leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Could bone marrow from deceased donors cure blood cancers?
Cure Not yet recruitingThis study tests whether bone marrow from deceased donors can be used to treat people with blood cancers like leukemia and lymphoma. Participants receive a transplant of cryopreserved marrow from a deceased donor or standard cells from a living donor. The goal is to see if the de…
Sponsor: Ossium Health, Inc. • Aim: Cure
Last updated Sep 12, 2026 00:00 UTC
-
Can Exercise-Powered immune cells stop leukemia from coming back?
Disease control Not yet recruitingThis early-phase trial tests a new approach using donor immune cells that have been mobilized through exercise to prevent or treat leukemia relapse after a stem cell transplant. The study will enroll 94 people with various blood cancers. Some will receive the exercise-mobilized c…
Phase 1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for rare leukemia: drug cocktail shows promise
Disease control Not yet recruitingThis study tests a combination of two newer drugs, blinatumomab and venetoclax, along with standard chemotherapy, for adults with a rare type of leukemia called acute leukemia of ambiguous lineage (ALAL). The goal is to see if this approach improves survival and remission rates. …
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Tweaking donor cells may shield older transplant patients from a dangerous complication
Prevention Not yet recruitingResearchers are testing whether removing a specific type of immune cell, called CD45RA-positive naive T cells, from donor stem cells can prevent graft-versus-host disease in older adults undergoing stem cell transplants for acute leukemia or myelodysplastic syndrome. The trial en…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC